Lady Davis Institute – Bloomfield Centre for Research in Aging

The Bloomfield Centre for Research in Aging (BCRA) was established in 1989 to promote research into all aspects of aging, concentrating on cellular and molecular mechanisms of healthy aging and age-related diseases.  The Centre occupies the fourth floor of the Lady Davis Institute for Medical Research at the Jewish General Hospital, a McGill teaching hospital.

Research activities are focused in six areas:

  • Basic cellular mechanisms of aging
  • Basic mechanisms of neurodegenerative disease
  • Clinical research into aging and dementia
  • Population studies of aging and dementia
  • Health services delivery to the elderly
  • Aging Bone, bone cell differentiation, Apoptosis and Aging


Here is a list of faculty members currently conducting neuroscience-related research.  Follow the links to read about each investigator's research interests, publications and the work being done in their laboratory.


Tel: (514) 340-8260 loc. 5129
E-mail: howard.chertkow [at]

Research:  Alzheimer's Disease and dementia.

Dr. Chertkow's field of research is cognitive neuroscience - it attempts to understand the brain basis of behaviour using studies of normal subjects, brain imaging, and testing of individuals with brain damage. His initial focus was cognitive neuropsychological investigations of one component of long-term memory, namely semantic memory.


Department of Neurology and Neurosurgery, McGill University

Tel: (514) 340-8222 loc. 4837 / (514) 340-8222 loc. 4976
E-mail: andrea.leblanc [at]

Research:  Pathophysiology of neurodegenerative diseases in aging individuals.

The long-term objective of Dr. LeBlanc’s research is to investigate the mechanisms responsible for the pathophysiology of neurodegenerative diseases in aging individuals. Her main research goal is to test the hypothesis that unscheduled death of neurons may be the leading physiological abnormality contributing to the loss of critical a mass of functional neurons in the central nervous system (CNS), and that this loss is the underlying cellular reason for the CNS deficit in Alzheimer's Disease (AD) and other neurodegenerative diseases. Her laboratory investigates various cell death pathways in human primary neuron cultures and their role in AD and prion disease pathology.


Department of Neurology and Neurosurgery, McGill University

Tel: (514) 340-8260 loc. 4866
E-mail: hpaude [at]

Research: Elucidate the molecular mechanism of tau phosphorylation in normal brain and to determine how this regulation fails in Alzheimer's disease brain.

Senile plaques and neurofibrillary tangles (NTs) are the two neuropathological hallmarks of AD. The extended topographical distribution of NTs provides a reliable pathological correlation to the degree of dementia, the central symptom of AD. Ultrastructurally, NTs contain paired helical filaments (PHFs). PHFs are composed of abnormally hyperphosphorylated microtubule-associated tau protein. Carrying more phosphate than it should makes tau unable to perform its normal function leading to loss of tau function, cytoskeletal disruption, PHF formation, and neurodegeneration.


Departments of Neurology & Neurosurgery and Medicine (Geriatrics), McGill University

Tel: (514) 340-8260 loc. 5588
E-mail: hyman.schipper [at]

Research:  Neuroendocrinology, Brain Aging, Oxidative Stress and Neurodegenerative Disease.

Since 1976, Dr. Schipper’s research efforts have been largely concentrated at the intersections of Neuroendocrinology, Brain Aging, and Neurodegenerative Disease. Three papers (1980-3) provided the earliest published evidence that chronic exposure to ovarian estradiol promotes aging-related degenerative (neuritic and glial) changes in the rodent hypothalamus implicated in reproductive senescence and the development of polycystic ovaries.